Is the CHOP Regimen a Good Treatment for Advanced CLL? Results from two Randomized Clinical Trials

References

• French Cooperative Group on chronic lymphocytic leukemia. Prognostic and therapeutic advances in chronic lymphocytic leukemia management: the experience of the French Cooperative Group. Semin. Hematol. 1987; 24: 275–290
   PubMed Web of Science ®Google Scholar
• Dighiero G., Travade Ph., Chevret S., Fenaux P., Chas-Tang C, Binet J. L., The French Cooperative Group on CLL. B-cell chronic lymphocytic leukemia: Present status and future directions. Blood 1991; 78: 1901–1914
   PubMed Web of Science ®Google Scholar
• International Workshop on chronic lymphocytic leukemia. Chronic lymphocytic leukemia: recommendations for diagnosis, staging and response criteria. Ann. Intern. Med. 1989; 110: 236–238
   PubMed Web of Science ®Google Scholar
• Catovsky D. The treatment of CLL: Summing up. Leukemia and Lymphoma 1991; 5(Suppl. 1)149–150
   Web of Science ®Google Scholar
• Rai K., Sawitsky A., Cronkite E., Chanana A. B., Leey R. N., Pasternack B. S. Clinical staging of chronic lymphocytic leukemia. Blood 1975; 46: 219–234
   PubMed Web of Science ®Google Scholar
• Foon K. A., Rai K. R., Gale R. P. Chronic lymphocytic leukemia: new insights into biology and therapy. Ann. Intern. Med. 1990; 113: 525–539
   PubMed Web of Science ®Google Scholar
• Binet J. L., Auquier A., Dighiero G., Chastang C., Pi-Guet H, Goasguen J., Vaugier G., Potron G., Colona P., Thomas M., Tchernia G., Jacquillat C., Boivin P., Lesty C., Duault M. T., Montconduit M. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 1981; 48: 198–206
   PubMed Web of Science ®Google Scholar
• French Cooperative Group on CLL: Benefit of the CHOP regimen in advanced untreated CLL. Results from a randomized clinical trial. Lancet 1986; i: 1346–1349
   Google Scholar
• French Cooperative Group on CLL. Long-term results of the CHOP regimen in stage C chronic lymphocytic leukemia. Br. J. Haematol. 1989; 73: 334–340
   PubMed Web of Science ®Google Scholar
• French Cooperative Group on Chronic Lymphocytic Leukemia. A randomized clinical trial of chlorambucil versus COP in stage B chronic lymphocytic leukemia. Blood 1990; 75: 1422–1425
   PubMed Web of Science ®Google Scholar
• Bennett J. M. The use of “CHOP” in the treatment of chronic lymphocytic leukemia. Br. J. Haematol. 1990; 74: 546
   PubMed Web of Science ®Google Scholar
• Hansen M. M., Anderson E., Birgens H., Christensen B. E., Christensen T. G., Geisler Meldgaard C., Ped-Ersen D. CHOP versus chlorambucil + prednisone in chronic lymphocytic leukemia. Leukemia and Lymphoma 1991; 5(Suppl. 1)97–100
   Web of Science ®Google Scholar
• Jaksic B., Brujiatielli M. High dose chlorambucil for the treatment of B-chronic lymphocytic leukemia (CLL). Update of I.G.C.I. CLL trials. Proc. 5th Int. Workshop on CLL. Sitges, Barcelona 1991; 62
   Google Scholar
• Keating M. J., Scouros M., Murphy S., Kantarjian H., Hester J., McCredie K. B., Hersh M., Freireich E. J. Multiple agent chemotherapy (POACH) in previously treated and untreated patients with chronic lymphocytic leukemia. Leukemia 1988; 2: 157
   PubMed Web of Science ®Google Scholar
• Keating M. J., Hester J. P., McCredie K. B., Burgess M. A., Murphy W. K., Freireich F. J. Long-term results of CCAP therapy in chronic lymphocytic leukemia. Leukemia and Lymphoma 1990; 2: 391
   PubMed Web of Science ®Google Scholar
• Kimby E., Mellstedt H. Chlorambucil/prednisone versus CHOP in symptomatic chronic lymphocytic leukemia. Leukemia and Lymphoma 1991; 5: 93
   PubMed Web of Science ®Google Scholar
• George S. L., Desu M. M. Planning the size and duration of a clinical trial studying the time to some critical event. J. Chron. Dis. 1974; 87: 15–24
   Google Scholar
• Kaplan E., Meier P. Non parametric estimation from incomplete observations. J. Am. Stat. Assoc 1958; 53: 457–481
   Web of Science ®Google Scholar
• Peto R., Peto J. Asymptotically efficient rank invariant test procedures (with discussion). J. R. Stat. Soc. A 1972; 135: 185–193
   Web of Science ®Google Scholar
• Cox D. R. Regression models and life tables (with discussion). J. R. Stat. Soc. B. 1972; 34: 187–220
   Google Scholar
• Montserrat E., Alcala A., Parody R., Domingo A., Gar-cia-Conde J., Bueno J., Ferran C., Sanz M. A., Girald M., Rubio D., Anton I., Estape J., Rozman C., participating members of PETHEMA. Treatment of chronic lymphocytic leukemia in advanced stages: a randomized trial comparing chlorambucil plus prednisone vs cyclophosphamide, vincristin and prednisome. Cancer 1985; 56: 2369–2375
   PubMed Web of Science ®Google Scholar
• Hansen M. M. Chronic lymphocytic leukemia. Clinical studies based on 189 cases followed for a long time. Scand. J. Haematol. 1973; 18(Suppl.)3
   Google Scholar
• Anderson J. R., Cain K. C., Gelber R. D., Gelman R. S. Analysis and interpretation of the comparison of survival by treatment outcome variables in cancer clinical trials. Cancer, Treat. Rep. 1985; 69: 1139–1145
   PubMedGoogle Scholar
• Keating M. J., Kantarjian M., Redman J., Koller C., Bar-Logie B, Velasquez W., Plunkett W., Freireich E. J., McCredie K. B. Fludarabine: a new agent with major activity against chronic lymphocytic leukemia. Blood 1989; 74: 19–25
   PubMed Web of Science ®Google Scholar
• Keating M. J. Fludarabine phosphate in the treatment of chronic lymphocytic leukemia. Semin. Oncol. 1990; 17(Suppl. 8)49–62
   PubMedGoogle Scholar
• Dillman R. O., Mick R., McLntyre O. K. Pen-tostatin in chronic lymphocytic leukemia: a phase II trial of cancer and leukemia group. Br. J. Clin. Oncol. 1989; 7: 433–438
   PubMed Web of Science ®Google Scholar
• Piro L. D., Carrera C. J., Beutler E., Carson D. A. Chorodeoxyadenosine: an effective new agent for the treatment of chronic lymphocytic leukemia. Blood 1988; 72: 1069–1073
   PubMed Web of Science ®Google Scholar